GSK3β and tau protein in Alzheimer's disease and epilepsy

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.

Buée, L., Bussière, T., Buée‐Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,007 · see citing works

Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · see citing works

Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780 · see citing works

The GSK3 hypothesis of Alzheimer’s disease

Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191 · see citing works

Differential Regulation of Dynein and Kinesin Motor Proteins by Tau

Dixit, R., Ross, J. L., Goldman, Y. E., & Holzbaur, E. L. F. (2008) · Science · doi:10.1126/science.1152993 · Cited by 1,012 · see citing works

Tau phosphorylation: the therapeutic challenge for neurodegenerative disease

Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965 · see citing works

The many faces of tau

Morris, M., Maeda, S., Vossel, K., & Mucke, L. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.009 · Cited by 899 · see citing works

Alzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules

Alonso, A. D. C., Grundke-Iqbal, I., & Iqbal, K. (1996) · Nature Medicine · doi:10.1038/nm0796-783 · Cited by 859 · see citing works

Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau)

Wood, J. G., Mirra, S. S., Pollock, N. J., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4040 · Cited by 749 · see citing works

LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β

Peineau, S., Taghibiglou, C., Bradley, C. A., Wong, T. P., Liu, L., Lu, J., Lo, E., Wu, D., Saule, E., Bouschet, T., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.029 · Cited by 690 · see citing works

Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease

Roberson, E. D., Halabisky, B., Yoo, J. W., Yao, J., Chin, J., Yan, F., Wu, T., Hamto, P., Devidze, N., Yu, G.-Q., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4152-10.2011 · Cited by 654 · see citing works

Post-translational modifications of tau protein: Implications for Alzheimer's disease

Martin, L., Latypova, X., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.023 · Cited by 645 · see citing works

Tau protein kinases: Involvement in Alzheimer's disease

Martin, L., Latypova, X., Wilson, C. M., Magnaudeix, A., Perrin, M.-L., Yardin, C., & Terro, F. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.003 · Cited by 631 · see citing works

Structure and novel exons of the human .tau. gene

Andreadis, A., Brown, W. M., & Kosik, K. S. (1992) · Biochemistry · doi:10.1021/bi00158a027 · Cited by 625 · see citing works

Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits

Min, S.-W., Chen, X., Tracy, T. E., Li, Y., Zhou, Y., Wang, C., Shirakawa, K., Minami, S. S., Defensor, E., Mok, S. A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3951 · Cited by 516 · see citing works

Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly

Hasegawa, M., Smith, M. J., & Goedert, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01217-4 · Cited by 482 · see citing works

Inhibitory Phosphorylation of Glycogen Synthase Kinase-3 (GSK-3) in Response to Lithium

Zhang, F., Phiel, C. J., Spece, L. J., Gurvich, N., & Klein, P. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212635200 · Cited by 436 · see citing works

Neuropsychological effects of epilepsy and antiepileptic drugs

Kwan, P., & Brodie, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03600-x · Cited by 434 · see citing works

Seizures and Epilepsy After Ischemic Stroke

Camilo, O., & Goldstein, L. B. (2004) · Stroke · doi:10.1161/01.str.0000130989.17100.96 · Cited by 429 · see citing works

Inflammatory process in Alzheimer's Disease

Meraz-Ríos, M. A., Toral-Rios, D., Franco-Bocanegra, D., Villeda-Hernández, J., & Campos-Peña, V. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00059 · Cited by 427 · see citing works

GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease

Cruchaga, C., Kauwe, J. S. K., Harari, O., Jin, S. C., Cai, Y., Karch, C. M., Benitez, B. A., Jeng, A. T., Skorupa, T., Carrell, D., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.026 · Cited by 383 · see citing works

Glycogen Synthase Kinase-3 (GSK3) in Psychiatric Diseases and Therapeutic Interventions

Jope, R. S., & Roh, M. (2006) · Current Drug Targets · doi:10.2174/1389450110607011421 · Cited by 382 · see citing works

Glycogen Synthase Kinase-3β Phosphorylates Bax and Promotes Its Mitochondrial Localization during Neuronal Apoptosis

Linseman, D. A., Butts, B. D., Precht, T. A., Phelps, R. A., Le, S. S., Laessig, T. A., Bouchard, R. J., Florez‐McClure, M. L., & Heidenreich, K. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2057-04.2004 · Cited by 370 · see citing works

A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo

Serenó, L., Coma, M., Rodríguez, M., Sánchez-Ferrer, P., Sánchez, M. B., Gich, I., Agulló, J. M., Pérez, M., Avila, J., Guardia-Laguarta, C., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.025 · Cited by 368 · see citing works

Cognitive impairment in epilepsy: the role of network abnormalities

Holmes, G. L. (2015) · Epileptic Disorders · doi:10.1684/epd.2015.0739 · Cited by 334 · see citing works

Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases

Andreadis, A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.010 · Cited by 311 · see citing works

Antisense Reduction of Tau in Adult Mice Protects against Seizures

DeVos, S. L., Goncharoff, D. K., Chen, G., Kebodeaux, C. S., Yamada, K., Stewart, F. R., Schuler, D. R., Maloney, S. E., Wozniak, D. F., Rigo, F., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2107-13.2013 · Cited by 311 · see citing works

Tau domains, phosphorylation, and interactions with microtubules

Mandelkow, E.-M., Biernat, J., Drewes, G., Gustke, N., Trinczek, B., & Mandelkow, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00025-a · Cited by 308 · see citing works

Microtubule-associated protein tau is essential for long-term depression in the hippocampus

Kimura, T., Whitcomb, D. J., Jo, J., Regan, P., Piers, T., Heo, S., Brown, C., Hashikawa, T., Murayama, M., Seok, H., et al. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0144 · Cited by 307 · see citing works

Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections.

Tai, X. Y., Koepp, M., Duncan, J. S., Fox, N., Thompson, P., Baxendale, S., Liu, J. Y. W., Reeves, C., Michalak, Z., & Thom, M. (2016) · Brain · doi:10.1093/brain/aww187 · Cited by 291 · see citing works

Interaction of Endogenous Tau Protein with Synaptic Proteins Is Regulated by N-Methyl-d-aspartate Receptor-dependent Tau Phosphorylation*

Mondragón-Rodríguez, S., Trillaud-Doppia, E., Dudilot, A., Bourgeois, C., Lauzon, M., Leclerc, N., & Boehm, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401240 · Cited by 272 · see citing works

Exposure of rat hippocampal neurons to amyloid β peptide (25–35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β

Takashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K., & Imahori, K. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12257-5 · Cited by 260 · see citing works

The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts

Myers, A., Pittman, A. M., Zhao, A. S., Rohrer, K., Kaleem, M. A., Marlowe, L., Lees, A. J., Leung, D. G., McKeith, I. G., Perry, R. H., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.018 · Cited by 254 · see citing works

Tau Loss Attenuates Neuronal Network Hyperexcitability in Mouse and <i>Drosophila</i> Genetic Models of Epilepsy

Holth, J. K., Bomben, V. C., Reed, J. G., Inoue, T., Younkin, L., Younkin, S. G., Pautler, R. G., Botas, J., & Noebels, J. L. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3191-12.2013 · Cited by 238 · see citing works

Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer’s disease

Cumbo, E., & Ligori, L. D. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.01.015 · Cited by 216 · see citing works

The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease

Inestrosa, N. C., & Toledo, E. M. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-9 · Cited by 206 · see citing works

Tau Phosphorylation at Serine 396 Residue Is Required for Hippocampal LTD

Regan, P., Piers, T., Yi, J.-H., Kim, D.-H., Huh, S., Park, S. J., Ryu, J. H., Whitcomb, D. J., & Cho, K. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2842-14.2015 · Cited by 202 · see citing works

The active form of glycogen synthase kinase-3? is associated with granulovacuolar degeneration in neurons in Alzheimer's disease

Boutajangout, A., Leroy, K., Authelet, M., Anderton, B. H., Brion, J., & Woodgett, J. R. (2002) · Acta Neuropathologica · doi:10.1007/s004010100435 · Cited by 186 · see citing works

Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults

Meador, K. J., Loring, D. W., Moore, E. E., Thompson, W. O., Nichols, M., Oberzan, R. L., Durkin, M. W., Gallagher, B. B., & King, D. W. (1995) · Neurology · doi:10.1212/wnl.45.8.1494 · Cited by 172 · see citing works

Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies

Goedert, M. (1999) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1999.0466 · Cited by 171 · see citing works

Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study.

Thom, M., Liu, J. Y. W., Thompson, P., Phadke, R., Narkiewicz, M., Martinian, L., Marsdon, D., Koepp, M., Caboclo, L., Catarino, C. B., et al. (2011) · Brain · doi:10.1093/brain/awr209 · Cited by 167 · see citing works

GSK3 Function in the Brain during Development, Neuronal Plasticity, and Neurodegeneration

Salcedo‐Tello, P., Ortiz‐Matamoros, A., & Arias, C. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/189728 · Cited by 163 · see citing works

Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy

Fritz, N. E., Glogau, S., Hoffmann, J. M., Rademacher, M., Elger, C. E., & Helmstaedter, C. (2005) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.01.002 · Cited by 158 · see citing works

An Overview on the Clinical Development of Tau-Based Therapeutics

Medina, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041160 · Cited by 156 · see citing works

Tau Phosphorylation at Serine 396 and Serine 404 by Human Recombinant Tau Protein Kinase II Inhibits Tau's Ability to Promote Microtubule Assembly

EVANS, D. B., Rank, K. B., Bhattacharya, K., Thomsen, D. R., Gurney, M. E., & Sharma, S. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000808200 · Cited by 155 · see citing works

Tau-Dependent Kv4.2 Depletion and Dendritic Hyperexcitability in a Mouse Model of Alzheimer's Disease

Hall, A. M., Throesch, B. T., Buckingham, S. C., Markwardt, S. J., Peng, Y., Wang, Q., Hoffman, D. A., & Roberson, E. D. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2552-14.2015 · Cited by 153 · see citing works

Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy

Lohi, H., Ianzano, L., Zhao, X.-C., Chan, E. M., Turnbull, J., Scherer, S. W., Ackerley, C. A., & Minassian, B. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi306 · Cited by 153 · see citing works

Seizures in Alzheimer Disease: Clinical and Epidemiological Data

Pandis, D., & Scarmeas, N. (2012) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-12.5.184 · Cited by 153 · see citing works

Effects of Gabapentin and Carbamazepine on the EEG and Cognition in Healthy Volunteers

Salinsky, M., Binder, L. M., Oken, B., Storzbach, D. M., Aron, C. R., & Dodrill, C. B. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.22501.x · Cited by 141 · see citing works

Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion

Ahmed, T., Van der Jeugd, A., Blum, D., Galas, M.-C., D’Hooge, R., Buee, L., & Balschun, D. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.005 · Cited by 137 · see citing works

Differential Cognitive Effects of Carbamazepine and Gabapentin

Meador, K. J., Loring, D. W., Ray, P. G., Murro, A. M., King, D. W., Nichols, M., Deer, E. M., & Goff, W. T. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00858.x · Cited by 135 · see citing works

Impact of Valproate and Phenytoin on Cognitive Function in Elderly Patients: Results of a Single‐Blind Randomized Comparative Study

Craig, I. R., & Tallis, R. C. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02448.x · Cited by 132 · see citing works

Glycogen synthase kinase‐3β, or a link between amyloid and tau pathology?

Muyllaert, D., Kremer, A., Jaworski, T., Borghgraef, P., Devijver, H., Croes, S., Dewachter, I., & Leuven, F. V. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00376.x · Cited by 130 · see citing works

Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease

Bulic, B., Pickhardt, M., & Mandelkow�, E. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3017317 · Cited by 116 · see citing works

Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits

de Barreda, E. G., Pérez, M., Gómez‐Ramos, P., de Cristóbal, J., Martín-Maestro, P., Morán, A., Dawson, H. N., Vitek, M. P., Lucas, J. J., Hernández, F., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.017 · Cited by 112 · see citing works

Induction of the Wnt Inhibitor, Dickkopf‐1, Is Associated with Neurodegeneration Related to Temporal Lobe Epilepsy

Busceti, C. L., Biagioni, F., Aronica, E., Riozzi, B., Storto, M., Battaglia, G., Giorgi, F. S., Gradini, R., Fornai, F., Caricasole, A., et al. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01055.x · Cited by 102 · see citing works

Axonal degeneration in tauopathies: disease relevance and underlying mechanisms

Kneynsberg, A., Combs, B., Christensen, K., Morfini, G., & Kanaan, N. M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00572 · Cited by 102 · see citing works

Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology

Ahnaou, A., Moechars, D., Raeymaekers, L., Biermans, R., Manyakov, N. V., Bottelbergs, A., Wintmolders, C., Van Kolen, K., Van De Casteele, T., Kemp, J. A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13839-6 · Cited by 98 · see citing works

New Features about Tau Function and Dysfunction

Medina, M., Hernández, F., & Ávila, J. (2016) · Biomolecules · doi:10.3390/biom6020021 · Cited by 92 · see citing works

Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition

Kauwe, J. S. K., Cruchaga, C., Mayo, K., Fenoglio, C., Bertelsen, S. E., Nowotny, P., Galimberti, D., Scarpini, E. A., Morris, J. C., Fagan, A. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801227105 · Cited by 89 · see citing works

Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead

Novak, P., Kontsekova, E., Zilka, N., & Novak, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00798 · Cited by 87 · see citing works

Phosphorylation of Tau proteins: a major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome

Flament, S., Delacourte, A., & Mann, D. M. A. (1990) · Brain Research · doi:10.1016/0006-8993(90)90891-e · Cited by 86 · see citing works

Regulation of Cell Survival Mechanisms in Alzheimer′s Disease by Glycogen Synthase Kinase‐3

Mines, M. A., Beurel, E., & Jope, R. S. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/861072 · Cited by 85 · see citing works

Kainate induces AKT, ERK and cdk5/GSK3β pathway deregulation, phosphorylates tau protein in mouse hippocampus

Crespo‐Biel, N., Canudas, A. M., Camins, A., & Pallàs, M. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.10.002 · Cited by 82 · see citing works

Comparative Cognitive Effects of Carbamazepine and Gabapentin in Healthy Senior Adults

Martin, R. C., Meador, K. J., Turrentine, L., Faught, E., Sinclair, K., Kuzniecky, R., & Gilliam, F. G. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.33300.x · Cited by 78 · see citing works

Pathological Tau Tangles Localize to Focal Cortical Dysplasia in Older Patients

Sen, A., Thom, M., Martinian, L., Harding, B. N., Cross, J. H., Nikolić, M., & Sisodiya, S. M. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01107.x · Cited by 71 · see citing works

Memory and psychomotor effects of oxcarbazepine in healthy human volunteers

Curran, H. V., & Java, R. I. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf02440853 · Cited by 69 · see citing works

Tau-induced pathology in epilepsy and dementia: notions from patients and animal models.

Sánchez, M., García-Cabrero, A., Sánchez-Elexpuru, G., Burgos, D., & Serratosa, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041092 · Cited by 68 · see citing works

Antiglutamatergic therapy in Alzheimer's disease - effects of lamotrigine

Tekin, S., Bingöl, C. A., Tanrıdağ, T., & Aktan, S. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050059 · Cited by 64 · see citing works

Tau Phosphorylation, Aggregation, and Cell Toxicity

Ávila, J., Santa‐María, I., Pérez, M., Hernández, F., & Moreno, F. J. (2006) · BioMed Research International · doi:10.1155/jbb/2006/74539 · Cited by 59 · see citing works

The Role of Wnt/β-Catenin Signaling Pathway in Disrupted Hippocampal Neurogenesis of Temporal Lobe Epilepsy: A Potential Therapeutic Target?

Huang, C. Y., Fu, X., Zhou, D., & Li, J. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1614-1 · Cited by 54 · see citing works

Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies

Bittar, A., Sengupta, U., & Kayed, R. (2018) · npj Vaccines · doi:10.1038/s41541-018-0046-8 · Cited by 50 · see citing works

Identification of GSK-3 as a potential therapeutic entry point for epilepsy.

Aourz, N., Serruys, A.-S. K., Chabwine, J. N., Balegamire, P. B., Afrikanova, T., Edrada-Ebel, R., Grey, A. I., Kamuhabwa, A. R., Walrave, L., Esguerra, C. V., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00281 · Cited by 49 · see citing works

Lovastatin Modulates Glycogen Synthase Kinase-3β Pathway and Inhibits Mossy Fiber Sprouting after Pilocarpine-Induced Status Epilepticus

Lee, C.-Y., Jaw, T., Tseng, H., Chen, I., & Liou, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038789 · Cited by 40 · see citing works

Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus

Engel, T., Gómez‐Sintes, R., Alves, M., Jimenez-Mateos, E. M., Fernández‐Nogales, M., Sanz‐Rodriguez, A., Morgan, J., Beamer, E. H., Rodríguez-Matellán, A., Dunleavy, M., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0963-5 · Cited by 37 · see citing works

Designing of dual inhibitors for GSK-3β and CDK5: Virtual screening andin vitrobiological activities study

Xie, H., Wen, H., Zhang, D., Liu, L., Liu, B., Liu, Q., Jin, Q., Ke, K., Hu, M., & Chen, X. (2017) · Oncotarget · doi:10.18632/oncotarget.15085 · Cited by 31 · see citing works

GSK3β Activity Alleviates Epileptogenesis and Limits GluA1 Phosphorylation

Urbańska, M., Kaźmierska, P., Kowalczyk, T., Caban, B., Nader, K., Pijet, B., Kalita, K. B., Góźdź, A., Devijver, H., Lechat, B., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.040 · Cited by 31 · see citing works

N-methyl-D-aspartate receptors mediate epilepsy-induced axonal impairment and tau phosphorylation via activating glycogen synthase kinase-3β and cyclin-dependent kinase 5.

Liu, X., Ou, S., Yin, M., Xu, T., Wang, T., Liu, Y. M., Ding, X., Yu, X., Yuan, J., Huang, H., et al. (2017) · PubMed · Cited by 30 · see citing works

Kainic acid-induced seizures activate GSK-3β in the hippocampus of D2R−/− mice

Tripathi, P. P., Santorufo, G., Brilli, E., Borrelli, E., & Bozzi, Y. (2010) · Neuroreport · doi:10.1097/wnr.0b013e32833d5891 · Cited by 29 · see citing works

Effect of Divalproex Sodium on Behavioural and Cognitive Problems in Elderly Dementia

Meinhold, J. M., Blake, L. M., Mini, L. J., Welge, J. A., Schwiers, M., & Hughes, A. (2005) · Drugs & Aging · doi:10.2165/00002512-200522070-00007 · Cited by 28 · see citing works

Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay

Holzer, M., Schade, N., Opitz, A., Hilbrich, I., Stieler, J., Vogel, T., Neukel, V., Oberstadt, M., Totzke, F., Schächtele, C., et al. (2018) · Molecules · doi:10.3390/molecules23092335 · Cited by 28 · see citing works

Protective effects of lithium treatment for spatial memory deficits induced by tau hyperphosphorylation in splenectomized rats

Tan, W., Cao, X., Wang, J., Huang-wei, L., Wu, B., & Ma, H. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05433.x · Cited by 24 · see citing works

Mouse hippocampal phosphorylation footprint induced by generalized seizures: Focus on ERK, mTORC1 and Akt/GSK-3 pathways

Gangarossa, G., Sakkaki, S., Lory, P., & Valjent, E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.051 · Cited by 21 · see citing works

Activation of AKT/GSK3β pathway by TDZD-8 attenuates kainic acid induced neurodegeneration but not seizures in mice

Bhowmik, M., Khanam, R., Saini, N., & Vohora, D. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.11.008 · Cited by 21 · see citing works

Predicting the risk of poststroke epilepsy—why and how?

Kwan, J. S. K. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.140 · Cited by 17 · see citing works

Tau domains, phosphorylation, and interaction with microtubules

Ingram, V. M. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00031-9 · Cited by 8 · see citing works

Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease

Misrani, A., Tabassum, S., & Yang, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.617588 · Cited by 654 · see citing works

Apoptosis in Alzheimer’s disease: Insight into the signaling pathways and therapeutic avenues

Kumari, S., Dhapola, R., & Reddy, D. H. (2023) · Apoptosis · doi:10.1007/s10495-023-01848-y · Cited by 324 · see citing works

The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer’s Disease: Therapeutic Implications and Future Perspectives

Jurcău, M. C., Andronie-Cioara, F. L., Jurcău, A., Marcu, F., Ţiț, D. M., Pașcalău, N., & Nistor-Cseppentö, D. C. (2022) · Antioxidants · doi:10.3390/antiox11112167 · Cited by 226 · see citing works

Zebrafish as a model organism for neurodegenerative disease

Chia, K., Klingseisen, A., Sieger, D., & Priller, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.940484 · Cited by 134 · see citing works

Bioavailability of Hesperidin and Its Aglycone Hesperetin—Compounds Found in Citrus Fruits as a Parameter Conditioning the Pro-Health Potential (Neuroprotective and Antidiabetic Activity)—Mini-Review

Wdowiak, K., Walkowiak, J., Pietrzak, R., Bazan‐Wozniak, A., & Cielecka‐Piontek, J. (2022) · Nutrients · doi:10.3390/nu14132647 · Cited by 122 · see citing works

Heterocyclic Compounds: Pharmacology of Pyrazole Analogs From Rational Structural Considerations

Costa, R. F., Turones, L. C., Cavalcante, K. V. N., Júnior, I. A. R., Xavier, C. H., Rosseto, L. P., Napolitano, H. B., Castro, P. F. D. S., Neto, M. L. F., Galvão, G. M., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.666725 · Cited by 118 · see citing works

BACE1 Inhibitors for Alzheimer’s Disease: The Past, Present and Any Future?

Bazzari, F. H., & Bazzari, A. H. (2022) · Molecules · doi:10.3390/molecules27248823 · Cited by 115 · see citing works

Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease

Toniolo, S., Sen, A., & Husain, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239318 · Cited by 94 · see citing works

Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation

Calabrese, G., Molzahn, C. M., & Mayor, T. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102062 · Cited by 90 · see citing works

Cognitive disorder and dementia in type 2 diabetes mellitus

Ortíz, G. G., Huerta, M., González-Usigli, H., Torres-Sánchez, E. D., Delgado-Lara, D. L. C., Pacheco-Moisés, F. P., Mireles-Ramírez, M. A., Torres-Mendoza, B. M., Moreno-Cih, R. I., & Velázquez-Brizuela, I. E. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i4.319 · Cited by 90 · see citing works

Oxidative stress–mediated neuroinflammation in Alzheimer’s disease

Firdous, S. M., Khan, S. A., & Maity, A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03188-3 · Cited by 85 · see citing works

Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies

Meng, K., Jia, H., Hou, X., Zhu, Z., Lu, Y., Feng, Y., Feng, J., Xia, Y., Tan, R., Cui, F., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13020327 · Cited by 80 · see citing works

Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer’s Disease

Shri, S. R., Manandhar, S., Nayak, Y., & Pai, K. S. R. (2023) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2023.071 · Cited by 71 · see citing works

A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease

Maciejewska, K., Czarnecka, K., & Szymański, P. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00293-5 · Cited by 64 · see citing works

Glycogen synthase kinase-3: A potential target for diabetes

Teli, D., & Gajjar, A. K. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117406 · Cited by 66 · see citing works

Natural Products and Their Neuroprotective Effects in Degenerative Brain Diseases: A Comprehensive Review

Lim, D. W., Lee, J., Lee, C.-H., & Kim, Y. T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011223 · Cited by 66 · see citing works

Akt signaling pathway: a potential therapy for Alzheimer’s disease through glycogen synthase kinase 3 beta inhibition

Limantoro, J., de Liyis, B. G., & Sutedja, J. C. (2023) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-023-00751-2 · Cited by 59 · see citing works

Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer’s Disease in Rat Model

Shehata, M. K., Ismail, A. A., & Kamel, M. A. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s417928 · Cited by 55 · see citing works

Cyanidin-3-O-glucoside protects the brain and improves cognitive function in APPswe/PS1ΔE9 transgenic mice model

Baek, H., Sanjay, S., Park, M., & Lee, H. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02950-3 · Cited by 55 · see citing works

Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015–2021)

Olekšák, P., Nepovimová, E., Chrienová, Ž., Musílek, K., Patočka, J., & Kuča, K. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114498 · Cited by 52 · see citing works

Recent Progress in the Development of New Antiepileptic Drugs with Novel Targets

Belete, T. M. (2023) · Annals of Neurosciences · doi:10.1177/09727531231185991 · Cited by 49 · see citing works

Nature's toolbox against tau aggregation: An updated review of current research

Khan, S., Hassan, M. I., Shahid, M., & Islam, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101924 · Cited by 50 · see citing works

Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease

Fernandes, F., Barroso, M. F., De Simone, A., Emriková, E., Dias-Teixeira, M., Pereira, J. P., Chlebek, J., Fernandes, V. C., Rodrigues, F., Andrisano, V., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115107 · Cited by 45 · see citing works

Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders

Loh, D., & Reiter, R. J. (2021) · Antioxidants · doi:10.3390/antiox10091483 · Cited by 43 · see citing works

Current research status of blood biomarkers in Alzheimer’s disease: Diagnosis and prognosis

Feng, L., Li, J., & Zhang, R. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101492 · Cited by 43 · see citing works

Multi-target approach to Alzheimer’s disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms

Abbas, K., Mustafa, M., Alam, M., Habib, S., Ahmad, W., Adnan, M., Hassan, M. I., & Usmani, N. (2025) · Neurogenetics · doi:10.1007/s10048-025-00821-y · Cited by 44 · see citing works

Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms

Hwang, K., Vaknalli, R. N., Addo-Osafo, K., Vicente, M., & Vossel, K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.903973 · Cited by 35 · see citing works

The Putative Role of Astaxanthin in Neuroinflammation Modulation: Mechanisms and Therapeutic Potential

Wang, S., & Qi, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.916653 · Cited by 39 · see citing works

Role of aluminum exposure on Alzheimer’s disease and related glycogen synthase kinase pathway

Sanajou, S., Erkekoğlu, P., Şahin, G., & Baydar, T. (2022) · Drug and Chemical Toxicology · doi:10.1080/01480545.2022.2065291 · Cited by 34 · see citing works

Advanced nano delivery system for stem cell therapy for Alzheimer's disease

Pan, Y., Li, L., Cao, N., Liao, J., Chen, H., & Zhang, M. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122852 · Cited by 32 · see citing works

From Fundamentals to Innovation in Alzheimer’s Disease: Molecular Findings and Revolutionary Therapies

Sighencea, M. G., Popescu, R. Ș., & Trifu, S. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212311 · Cited by 32 · see citing works

Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer’s Disease: Recent Trends and Future Development

Dave, B. P., Shah, Y. B., Maheshwari, K. G., Mansuri, M. K. A., Prajapati, B., Postwala, H. I., & Chorawala, M. R. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01408-7 · Cited by 32 · see citing works

Fibroblast growth factor 10 ameliorates neurodegeneration in mouse and cellular models of Alzheimer's disease via reducing tau hyperphosphorylation and neuronal apoptosis

Guo, K., Huang, W., Chen, K.-H.-Y., Huang, P., Peng, W., Shi, R.-Q., He, T., Zhang, M., Wang, H., Hu, J., et al. (2023) · Aging Cell · doi:10.1111/acel.13937 · Cited by 26 · see citing works

Inhibition of polyphenols on Maillard reaction products and their induction of related diseases: A comprehensive review

Ye, X., Zhang, M., Gong, Z., Jiao, W., Li, L., Dong, M., Xiang, T., Feng, N., & Wu, Q. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155589 · Cited by 30 · see citing works

GSK-3β dysregulation in aging: Implications for tau pathology and Alzheimer's disease progression

Rekha, A., Afzal, M., Babu, M. A., Menon, S. V., Nathiya, D., Supriya, S., Mishra, S. B., Gupta, S., Goyal, K., Rana, M., et al. (2025) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2025.104005 · Cited by 33 · see citing works

The Inflammatory Bridge Between Type 2 Diabetes and Neurodegeneration: A Molecular Perspective

Kacem, H., d’Angelo, M., Qosja, E., Topi, S., Castelli, V., & Cimini, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157566 · Cited by 33 · see citing works

Psychobiotics for Mitigation of Neuro‐Degenerative Diseases: Recent Advancements

Dhyani, P., Goyal, C., Dhull, S. B., Chauhan, A. K., Saharan, B. S., Harshita, Duhan, J. S., & Gökşen, G. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300461 · Cited by 30 · see citing works

Aβ1-42 promotes microglial activation and apoptosis in the progression of AD by binding to TLR4

Dou, R.-X., Zhang, Y., Hu, X., Gao, F.-L., Zhang, L., Liang, Y.-H., Zhang, Y.-Y., Yao, Y.-P., Li, Y., Zhang, Y., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103428 · Cited by 29 · see citing works

Mechanism of microglia-mediated neuroinflammation, associated cognitive dysfunction, and therapeutic updates in Alzheimer's disease

Ghimire, A., Rehman, S. A., Subhani, A., Khan, M. A., Rahman, Z., Iqubal, M. K., & Iqubal, A. (2025) · hLife · doi:10.1016/j.hlife.2024.11.006 · Cited by 30 · see citing works

On the relationships between epilepsy, sleep, and Alzheimer’s disease: A narrative review

Hanke, J.-M., Schindler, K. A., & Seiler, A. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108609 · Cited by 28 · see citing works

Cotinine and 6-Hydroxy-L-Nicotine Reverses Memory Deficits and Reduces Oxidative Stress in Aβ25-35-Induced Rat Model of Alzheimer’s Disease

Boiangiu, R. Ş., Mihăşan, M., Gorgan, L., Stache, A. B., Petre, B. A., & Hriţcu, L. (2020) · Antioxidants · doi:10.3390/antiox9080768 · Cited by 27 · see citing works

Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer’s Disease (Type 3 Diabetes)

de la Monte, S. M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230555 · Cited by 27 · see citing works

Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer’s Disease

Chávez-Castillo, M., Gotera, M. P., Durán, P., Diaz, M. P., Nava, M., Cano, C., Díaz-Camargo, E. A., Cano, G., Cano, R., Rivera-Porras, D., et al. (2025) · Molecules · doi:10.3390/molecules30153057 · Cited by 26 · see citing works

Mixture of Phlorotannin and Fucoidan from Ecklonia cava Prevents the Aβ-Induced Cognitive Decline with Mitochondrial and Cholinergic Activation

Han, H. J., Park, S. K., Kang, J. Y., Kim, J. M., Yoo, S. K., Kim, D., Kim, G., & Heo, H. J. (2021) · Marine Drugs · doi:10.3390/md19080434 · Cited by 28 · see citing works

Redox Imbalance as a Common Pathogenic Factor Linking Hearing Loss and Cognitive Decline

Paciello, F., Ripoli, C., Fetoni, A. R., & Grassi, C. (2023) · Antioxidants · doi:10.3390/antiox12020332 · Cited by 25 · see citing works

Evolving targets for anti-epileptic drug discovery

Raut, D., & Bhatt, L. K. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173582 · Cited by 25 · see citing works

Protein Homeostasis Networks and the Use of Yeast to Guide Interventions in Alzheimer’s Disease

Dhakal, S., & Macreadie, I. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218014 · Cited by 25 · see citing works

Mechanistic Intimate Insights into the Role of Hydrogen Sulfide in Alzheimer’s Disease: A Recent Systematic Review

Munteanu, C., Iordan, D. A., Hoteteu, M., Popescu, C., POSTOIU, R. L., Onu, I., & Onose, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015481 · Cited by 23 · see citing works

What is the Role of Lithium in Epilepsy?

Rao, C. M., Bojja, S. L., Singh, N., & Kolathur, K. K. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220411081728 · Cited by 23 · see citing works

The Major Hypotheses of Alzheimer’s Disease: Related Nanotechnology-Based Approaches for Its Diagnosis and Treatment

Cáceres, C., Heusser, B., Garnham, A., & Moczko, E. (2023) · Cells · doi:10.3390/cells12232669 · Cited by 23 · see citing works

The Cardiac Dysfunction Caused by Metabolic Alterations in Alzheimer's Disease

Murphy, J., Le, T. N. V., Fedorova, J., Yang, Y., Krause‐Hauch, M., Davitt, K., Zoungrana, L. I., Fatmi, M. K., Lesnefsky, E. J., Li, J., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.850538 · Cited by 22 · see citing works

The synergistic effect of nanocurcumin and donepezil on Alzheimer's via PI3K/AKT/GSK-3β pathway modulating

Beltagy, D. M., Nawar, N. F., Mohamed, T. M., Tousson, E., & El-Keey, M. M. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106791 · Cited by 22 · see citing works

Alzheimer’s Disease and Epilepsy: Exploring Shared Pathways and Promising Biomarkers for Future Treatments

Kalyvas, A.-C., Dimitriou, M., Ioannidis, P., Grigoriadis, N., & Afrantou, T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133879 · Cited by 20 · see citing works

Targeting lncRNA NEAT1 Hampers Alzheimer’s Disease Progression

Li, Y., Fan, H., Ni, M., Zhang, W., Fang, F., Sun, J., Lyu, P., & Ma, P. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.02.016 · Cited by 19 · see citing works

Melatonin and zinc supplements with physical and mental activities subside neurodegeneration and hepatorenal injury induced by aluminum chloride in rats: Inclusion of GSK-3β-Wnt/β-catenin signaling pathway

Abu‐Elfotuh, K., Hussein, F. H., Abbas, A. N., Al-Rekabi, M. D., Barghash, S. S., Zaghlool, S. S., & El‐Emam, S. Z. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.05.002 · Cited by 20 · see citing works

Involvement of inflammasomes in the pathogenesis of Alzheimer's disease

Beder, N., Belkhelfa, M., & Leklou, H. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241283677 · Cited by 19 · see citing works

Tangles and Plaques: A deep dive into the pathological hallmarks of Alzheimer’s disease

Vanya, Kumari, S., Bagri, K., & Deshmukh, R. R. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.10.050 · Cited by 18 · see citing works

DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer’s Disease-Down Syndrome Phenotypes

Zhu, B., Parsons, T., Stensen, W., Svendsen, J. S. M., Fugelli, A., & Hodge, J. J. L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.881385 · Cited by 18 · see citing works

Protective effects of apigenin in neurodegeneration: An update on the potential mechanisms

Mohammadkhanizadeh, A., Sheibani, M., Taherkhani, S., Nourabadi, D., Mohamadi-Zarch, S.-M., Nikbakht, F., & Azizi, Y. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100189 · Cited by 16 · see citing works

Posttranslational modifications & lithium’s therapeutic effect—Potential biomarkers for clinical responses in psychiatric & neurodegenerative disorders

Khayachi, A., Schorova, L., Alda, M., Rouleau, G. A., & Milnerwood, A. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.002 · Cited by 15 · see citing works

Nootropic foods in neurodegenerative diseases: mechanisms, challenges, and future

Nguyen, L. A. M., Simons, C. W., & Thomas, R. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00476-7 · Cited by 17 · see citing works

Analysis of Shared Genetic Regulatory Networks for Alzheimer’s Disease and Epilepsy

Wang, X., Liu, S., Lu, H. J., Guan, Y., Wu, H., & Ji, Y. (2021) · BioMed Research International · doi:10.1155/2021/6692974 · Cited by 15 · see citing works

A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies–Emphasis on Alzheimer’s Disease Pathogenesis

Shukla, M., Wongchitrat, P., & Govitrapong, P. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03530-2 · Cited by 15 · see citing works

Tau and GSK-3β are Critical Contributors to α-Synuclein-Mediated Post-Stroke Brain Damage

Mehta, S. L., Kim, T., Chelluboina, B., & Vemuganti, R. (2022) · NeuroMolecular Medicine · doi:10.1007/s12017-022-08731-0 · Cited by 16 · see citing works

A Mutual Nexus Between Epilepsy and α-Synuclein: A Puzzle Pathway

Ali, N. H., Al-kuraishy, H., Al-Gareeb, A., Alnaaim, S. A., Hetta, H., Saad, H., & Batiha, G. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04204-6 · Cited by 16 · see citing works

Behavioral Deficits in Mice with Postnatal Disruption ofNdel1in Forebrain Excitatory Neurons: Implications for Epilepsy and Neuropsychiatric Disorders

Gavrilovici, C., Jiang, Y., Kiroski, I., Sterley, T.-L., Vandal, M., Bains, J. S., Park, S. K., Rho, J. M., Teskey, G. C., & Nguyen, M. D. (2021) · Cerebral Cortex Communications · doi:10.1093/texcom/tgaa096 · Cited by 15 · see citing works

Hepatic and cardiac implications of increased toxic amyloid-beta serum level in lipopolysaccharide-induced neuroinflammation in rats: new insights into alleviating therapeutic interventions

Anwar, M. M., & Mabrouk, A. A. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01202-3 · Cited by 14 · see citing works

Neuronal–Glial Interaction in a Triple-Transgenic Mouse Model of Alzheimer’s Disease: Gene Ontology and Lithium Pathways

Rocha, N. K. R., Themoteo, R. M., Brentani, H., Forlenza, O. V., & de Paula, V. D. J. R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.579984 · Cited by 14 · see citing works

Discovery of GSK3β Inhibitors through In Silico Prediction-and-Experiment Cycling Strategy, and Biological Evaluation

Lee, Y., Yoon, S., Hong, H., Kim, H. Y., Jung, D., Moon, B.-S., Park, W., Lee, S., Kwon, H., Park, J., et al. (2022) · Molecules · doi:10.3390/molecules27123825 · Cited by 13 · see citing works

Oat Extract Avenanthramide-C Reverses Hippocampal Long-Term Potentiation Decline in Tg2576 Mice

Lee, Y., Wang, M., Son, Y., Yang, E. J., Kang, M.-S., Kim, H., Kim, H., & Jo, J. (2021) · Molecules · doi:10.3390/molecules26206105 · Cited by 12 · see citing works

A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet

Espinosa-Jiménez, T., Cano, A. C., Sánchez‐López, E., Olloquequi, J., Folch, J., Bulló, M., Verdaguer, E., Auladell, C., Pont, C., Muñoz‐Torrero, D., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01000-y · Cited by 12 · see citing works

Association of synaptic density and cognitive performance in temporal lobe epilepsy: Humans and animals PET imaging study with [ 18F ] SynVesT ‐1

Xiao, L., Xiang, S., Chen, C., Zhu, H., Zhou, M., Tang, Y., Feng, L., & Hu, S. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13682 · Cited by 13 · see citing works

Mechanisms of Phytoremediation by Resveratrol against Cadmium Toxicity

Mognetti, B., Franco, F., Castrignano, C., Bovolin, P., & Berta, G. N. (2024) · Antioxidants · doi:10.3390/antiox13070782 · Cited by 12 · see citing works

The Inflammation-Induced Dysregulation of Reelin Homeostasis Hypothesis of Alzheimer’s Disease

Reive, B. S., Lau, V. Z., Sánchez-Lafuente, C. L., Henri‐Bhargava, A., Kalynchuk, L. E., Tremblay, M., & Caruncho, H. J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240088 · Cited by 15 · see citing works

The Pluripotency Factor Nanog Protects against Neuronal Amyloid β-Induced Toxicity and Oxidative Stress through Insulin Sensitivity Restoration

Chang, C., Li, H., Tsou, S., Hung, H., Liu, G., Короленко, Т. А., Lai, T., Ho, Y., & Lin, C. (2020) · Cells · doi:10.3390/cells9061339 · Cited by 13 · see citing works

The bidirectional relationship between Alzheimer's disease (AD) and epilepsy: A Mendelian randomization study

Xu, L., & Wang, Q. (2023) · Brain and Behavior · doi:10.1002/brb3.3221 · Cited by 11 · see citing works

Ameliorative anti-coagulant, anti-oxidative and anti-ferroptotic activities of nanocurcumin and donepezil on coagulation, oxidation and ferroptosis in Alzheimer’s disease

Nawar, N. F., Beltagy, D. M., Mohamed, T. M., Tousson, E., & El-Keey, M. M. (2024) · Toxicology Research · doi:10.1093/toxres/tfae054 · Cited by 11 · see citing works

Computational and ADMET Predictions of Novel Compounds as Dual Inhibitors of BuChE and GSK-3β to Combat Alzheimer’s Disease

Londhe, S. G., Walhekar, V. S., Mangala, S. S., Kini, S. G., Scotti, M. T., Scotti, L., & Kumar, D. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16080991 · Cited by 11 · see citing works

Mitochondria-targeting by small molecules against Alzheimer's disease: A mechanistic perspective

Pal, C. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167617 · Cited by 12 · see citing works

RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer’s Disease

Medd, M. M., Yon, J. E., & Dong, H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020124 · Cited by 10 · see citing works

Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer’s Disease Hallmarks

Griñán‐Ferré, C., Jarné‐Ferrer, J., Bellver‐Sanchís, A., Ribalta‐Vilella, M., Barroso, E., Salvador, J. M., Jurado-Aguilar, J., Palomer, X., Vázquez‐Carrera, M., & Pallàs, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052595 · Cited by 10 · see citing works

mRNA and circRNA mislocalization to synapses are key features of Alzheimer’s disease

Smukowski, S. N., Danyko, C., Somberg, J., Kaufman, E. J., Course, M. M., Postupna, N. O., Barker‐Haliski, M. L., Keene, C. D., & Valdmanis, P. N. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011359 · Cited by 10 · see citing works

Zebrafish metabolomics: a comprehensive approach to understanding health and disease

Vivekaa, A., Nellore, J., & Sunkar, S. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01621-1 · Cited by 11 · see citing works

Investigation of Potential Drug Targets for Cholesterol Regulation to Treat Alzheimer’s Disease

Passero, M., Zhai, T., & Huang, Z. J. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20136217 · Cited by 10 · see citing works

The Association Between Alzheimer's Disease and Epilepsy: A Narrative Review

Purushotham, M., Tashrifwala, F. A. A., Jena, R., Vudugula, S. A., Patil, R. S., & Agrawal, A. (2022) · Cureus · doi:10.7759/cureus.30195 · Cited by 10 · see citing works

Dendrobine Ameliorates Alzheimer’s Disease-like Pathology and Cognitive Decline in 3 × Tg-AD Mice

Zhang, W., Huang, J., & Shi, J. (2024) · Brain Sciences · doi:10.3390/brainsci14030231 · Cited by 9 · see citing works

Integrated computational approaches for identification of potent pyrazole-based glycogen synthase kinase-3β (GSK-3β) inhibitors: 3D-QSAR, virtual screening, docking, MM/GBSA, EC, MD simulation studies

Niharika, D. G., Salaria, P., & Amarendar Reddy, M. (2024) · Molecular Diversity · doi:10.1007/s11030-024-11026-0 · Cited by 9 · see citing works

Cognitive and psychotic effects of ketamine “short- vs. long-term” therapy in a rat model of depression: Hippocampal TrkB/Akt/GSK-3β/mTOR/autophagy trajectories

Aref, S., Habib, M. Z., Eid, D., Eltantawy, E. H. B., Taeimah, M., Hassan, F. E., El‐Gabry, D. A., ElShahawi, H. H., Mohamad, M. I., Abdel-Tawab, A. M., et al. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111503 · Cited by 9 · see citing works

Neuronal insulin signaling and resistance: a balancing act of kinases and phosphatases

Sharma, M., Yadav, Y., & Dey, C. S. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0151 · Cited by 9 · see citing works

Beyond Amyloid: A Machine Learning-Driven Approach Reveals Properties of Potent GSK-3β Inhibitors Targeting Neurofibrillary Tangles

Nwadiugwu, M. C., Onwuekwe, I. O., Ezeanolue, E. E., & Deng, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052646 · Cited by 9 · see citing works

Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia

Behl, T., Arora, A., Sehgal, A., Singh, S., Sharma, N., Bhatia, S., Al‐Harrasi, A., BUNGAU, S. G., & Mostafavi, E. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666211110115257 · Cited by 9 · see citing works

Analysis of the potential and mechanism of Ginkgo biloba in the treatment of Alzheimer's disease based on network pharmacology

Huang, X., Li, T., Zhou, L., Liu, T., Xiong, L., & Yu, C. (2021) · Ibrain · doi:10.1002/j.2769-2795.2021.tb00060.x · Cited by 11 · see citing works

GSK3 Is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target

Hottin, C., Perron, M., & Roger, J. E. (2022) · Cells · doi:10.3390/cells11182898 · Cited by 9 · see citing works

Tauopathies: Emerging discoveries on tau protein, with a special focus on Alzheimer's disease

Hattiholi, A., Hegde, H., & Shetty, S. K. (2025) · Neuropeptides · doi:10.1016/j.npep.2025.102536 · Cited by 10 · see citing works

Regulation of eukaryotic protein kinases by Pin1, a peptidyl-prolyl isomerase

Chen, X., & Igumenova, T. I. (2022) · Advances in Biological Regulation · doi:10.1016/j.jbior.2022.100938 · Cited by 8 · see citing works

Reinstated Activity of Human Tau-induced Enhanced Insulin Signaling Restricts Disease Pathogenesis by Regulating the Functioning of Kinases/Phosphatases and Tau Hyperphosphorylation in Drosophila

Pragati, & Sarkar, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03599-y · Cited by 8 · see citing works

Gadd45A-mediated autophagy regulation and its impact on Alzheimer's disease pathogenesis: Deciphering the molecular Nexus

Althobaiti, N. A., Al-Abbas, N. S., Alsharif, I., Albalawi, A. E., Almars, ‏. I., Basabrain, A. A., Jafer, A., Ellatif, S. A. A., Bauthman, N. M., Almohaimeed, H. M., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167353 · Cited by 7 · see citing works

e-QSAR (Explainable AI-QSAR), molecular docking, and ADMET analysis of structurally diverse GSK3-beta modulators to identify concealed modulatory features vindicated by X-ray

Masand, V. H., Al‐Hussain, S. A., Masand, G. S., Samad, A., Gawali, R. G., Jadhav, S., & Zaki, M. E. A. (2024) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2024.108324 · Cited by 7 · see citing works

Unravelling the Role of Glycogen Synthase Kinase-3 in Alzheimer’s Disease-Related Epileptic Seizures

Lin, R., Jones, N. C., & Kwan, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103676 · Cited by 23 · see citing works

Glycogen Synthase Kinase-3 at the Intersection of Alzheimer’s Disease and Epilepsy

Lin, R. (2022) · Figshare · doi:10.26180/20297448

Mechanisms Involved in Epileptogenesis in Alzheimer’s Disease and Their Therapeutic Implications

Altuna, M., Olmedo‐Saura, G., Carmona‐Iragui, M., & Fortea, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084307 · Cited by 39 · see citing works

Cracking novel shared targets between epilepsy and Alzheimer’s disease: need of the hour

Garg, N., Joshi, R., & Medhi, B. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0064 · Cited by 21 · see citing works

Synergistic Effect between the APOE ε4 Allele with Genetic Variants of GSK3B and MAPT: Differential Profile between Refractory Epilepsy and Alzheimer Disease

Toral-Ríos, D., Pichardo‐Rojas, P. S., Ruiz-Sánchez, E., Rosas‐Carrasco, Ó., Carvajal-García, R., Gálvez-Coutiño, D. C., Martínez‐Rodríguez, N., Rubio-Chávez, A. D., Alcántara-Flores, M., López-Ramírez, A. M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810228 · Cited by 6 · see citing works